Manmeet Singh Soni Reata Pharmaceuticals Inc (RETA) insider trading activity

Manmeet Singh Soni is COO, CFO and President of REATA PHARMACEUTICALS INC. Currently has a direct ownership of 0 shares of RETA, which is worth approximately $0. The most recent transaction as insider was on Sep 26, 2023, when has been sold 62,621 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Manmeet Singh Soni Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 26 2023	SELL Sale (or disposition) back to the issuer	-	62,621 Reduced 100.0%	0 Class A Common Stock
Aug 16 2023	SELL Open market or private sale	$295,559 $168.41 p/Share	1,755 Reduced 2.73%	62,621 Class A Common Stock
Jul 28 2023	SELL Open market or private sale	$12,346,500 $164.62 p/Share	75,000 Reduced 53.81%	64,376 Class A Common Stock
Jul 28 2023	BUY Conversion of derivative security	-	75,000 Added 34.99%	139,376 Class A Common Stock
Jul 06 2023	BUY Grant, award, or other acquisition	-	6,000 Added 8.53%	64,376 Class A Common Stock
Jun 13 2023	SELL Open market or private sale	$8,034,165 $102.89 p/Share	78,085 Reduced 57.22%	58,376 Class A Common Stock
Jun 13 2023	BUY Exercise of conversion of derivative security	$683,000 $27.32 p/Share	25,000 Added 15.48%	136,461 Class A Common Stock

Jun 12 2023	SELL Open market or private sale	$469,309 $99.62 p/Share	4,711 Reduced 4.06%	111,461 Class A Common Stock
May 16 2023	SELL Open market or private sale	$50,581 $80.93 p/Share	625 Reduced 0.54%	116,172 Class A Common Stock
May 15 2023	SELL Open market or private sale	$1,826,804 $84.94 p/Share	21,507 Reduced 15.55%	116,797 Class A Common Stock
May 05 2023	BUY Grant, award, or other acquisition	-	50,000 Added 26.55%	138,304 Class A Common Stock
Mar 07 2023	SELL Open market or private sale	$52,677 $84.69 p/Share	622 Reduced 0.7%	88,304 Class A Common Stock
Mar 03 2023	SELL Open market or private sale	$315,548 $87.97 p/Share	3,587 Reduced 3.88%	88,926 Class A Common Stock
Jan 03 2023	BUY Grant, award, or other acquisition	-	23,513 Added 20.27%	92,513 Class A Common Stock
Jan 03 2022	BUY Grant, award, or other acquisition	-	50,000 Added 42.02%	69,000 Class A Common Stock
Dec 31 2021	BUY Open market or private purchase	$419,520 $26.22 p/Share	16,000 Added 45.71%	19,000 Class A Common Stock

Also insider at

SMMT

Summit Therapeutics Inc. Healthcare

Chief Operating Officer

PLSE

Pulse Biosciences, Inc. Healthcare

Director

MSS